Current commissioner, Scott Gottlieb, will be stepping down in April.
HealthDay News — The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb, M.D., leaves the post next month.
The appointment of Ned Sharpless, M.D., was announced Tuesday, a week after Gottlieb, who was in the position for two years, said he would step down in April. He has said he wants to spend more time with his family, the Associated Press reported.
Sharpless, who has led the National Cancer Institute since October 2017, is one of several government officials believed to be in the running to become the next FDA commissioner.
Continue Reading
A candidate for the position is nominated by the president and must be confirmed by the Senate.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. Read an unlimited amount by logging in or registering at no cost.
{{login-button}} {{register-button}}
Get the most out of Cardiology Advisor.
Register for free and enjoy unlimited access to:
- Clinical News
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.